Clinical trials
Hodgkin Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Bristol-Myers Squibb | 3 |
| UMC Utrecht | 2 |
| Celgene | 1 |
| Eisai Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| German Hodgkin's Lymphoma Study Group | 1 |
| Gilead Sciences | 1 |
| Leiden University Medical Center | 1 |
| Marjolein Spiering | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 26 |
| Lymphoma | 11 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Multiple Myeloma | 3 |
| Neoplasms | 3 |
| Recurrence | 3 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.